Market Call: Brianne Gardner's outlook on Canadian & U.S. Large Caps

Here's a comprehensive summary of the YouTube video transcript:

Key Concepts

• Economic Outlook (Canada & US): GDP growth, recession risks, consumer spending, inflation, interest rates, policy support.
• Investment Strategy: Cautious optimism, diversification, quality and durability of earnings, avoiding "zombie companies," high-grading holdings, cash on the sidelines, extreme greed/fear index.
• Sector Focus: Healthcare, Materials (precious metals), AI, Consumer Discretionary (luxury vs. staples), Energy, Financials, Utilities, Telecommunications, Medical Devices.
• Company Analysis: Valuation, fundamental strength, analyst ratings, price targets, dividend yields, P/E ratios, market capitalization, revenue streams, operational efficiency, balance sheets, leverage, competitive landscape.
• Specific Companies Discussed: Ferrari, CS Energy, Tamarack Valley Energy (TV), Fairfax Financial, Algonquin Power, Capital One, Discover, Costco, Meta Platforms, Eli Lilly, Telus, Canadian Natural Resources (CNQ), AltaGas, Couche-Tard, Constellation Energy, Microsoft, Boston Scientific.
• Market Indicators: Technical recession, P/E ratios, extreme greed/fear index, consensus buy ratings, price targets, intrinsic value, year-to-date performance, dividend yields.

Economic Overview and Market Sentiment

The discussion begins with an analysis of recent Canadian GDP numbers, which came in stronger than expected, suggesting a potential turnaround after nearly entering a technical recession in the previous two quarters. The Bank of Canada's rate cuts are seen as a positive move to aid the economy and potentially avoid a recession.

Despite this, consumer spending is down, indicating more cautious consumers and investors. While overall growth has cooled and inflation is easing, sentiment is swinging with each data release. Investors are shifting from focusing solely on outcomes to preparing for a range of scenarios. Consumer spending, particularly heading into Black Friday, Cyber Monday, and the holiday season, is expected to remain steady but with a pivot towards discounts.

In the US, attention is moving from interest rates to what matters for 2025, with the quality and durability of earnings being key market drivers. There's growing scrutiny around revenue circularity, especially in the AI sector, which is viewed as a healthy discipline. Key metrics to watch include customer expansion, diversified revenue, and improving margins for profitability.

The overall sentiment is cautiously optimistic, with a significant amount of cash still on the sidelines. The "extreme greed index" leaning towards "extreme fear" suggests investors are cautious, presenting potential buying opportunities.

Investment Strategy and Diversification

The prevailing investment strategy is one of cautious optimism, with a focus on diversification to prepare for various economic scenarios.

• Sector Rotation: A pickup is being observed in the Healthcare sector from a valuation standpoint, with P/E ratios starting to increase. Materials, particularly gold, silver, and precious metals, are expected to remain strong through 2025 and into 2026.
• AI Momentum: The AI sector is seen as having enduring momentum, even with recent sell-offs in major players like Microsoft and Meta.
• Geographic Diversification: The strategy considers Canada, the US, and international markets.
• Rate Cutting Cycle: The ongoing rate-cutting cycle is viewed as positive momentum for the equity market.
• Cash on the Sidelines: A significant amount of cash is waiting to re-enter the market.
• Portfolio Positioning: The view is to maintain a neutral equity allocation, avoid "zombie companies" (stagnant and unproductive), and lean on quality companies with strong profitability.
• Volatility as Opportunity: Expected volatility is seen as an opportunity to "high-grade" holdings, taking profits, cutting losses, and rotating into good quality companies.
• Outlook for 2026: The outlook for 2026 is generally optimistic, based on several factors.

Company-Specific Analysis and Recommendations

Several companies were discussed, with specific insights into their performance, fundamentals, and analyst outlooks:

Luxury Auto Sector:

• Ferrari (RACE): While not owned by the firm, Ferrari is seen as an extremely volatile stock. Wealthy shoppers tend to maintain spending during recessions. Analysts have a consensus "buy" rating with a significant upside potential (average price target around $420), but its volatility makes it too niche for their portfolio.

Energy Sector:

• CS Energy: Fundamentally ranks a 9/10. Year-to-date performance is up approximately 22.8%. Expected upside from a value perspective is 7-8%. Analysts have "buy to outperform" ratings. It's considered a fundamentally great quality company with a low dividend yield (around 1.5%).
• Tamarack Valley Energy (TV): A fast-growing small-cap Canadian oil producer, up around 65% year-to-date, driven by production growth and cost discipline. It remains sensitive to oil prices and operational risks. Analysts have a general consensus target of over $8, indicating single-digit upside potential. The stock has not consistently hit analyst targets in the past five years, suggesting it might be "priced for perfection." For new buyers, a pullback or consolidation is advised. A 10-15% pullback in energy stocks is considered normal volatility.
• Canadian Natural Resources (CNQ): Owned in the portfolio. An uptrend has been observed since the April pullback. It's one of Canada's largest oil and gas producers, focusing on low-cost production and operational efficiency with a strong balance sheet. The dividend is over 5%, with management having a track record of increasing payouts. Benefits from scale and integration. Value ranks 9/10, fundamentally 8/10. Adding or buying at current levels is recommended.

Financials:

• Fairfax Financial: A great Canadian company, ranking 8/10 for value and 9/10 fundamentally. Known for property and casualty insurance and investing in a wide range of companies. Potential upside of about 20% is seen. Up about 22% year-to-date, outperforming insurance peers. Trades at a reasonable P/E of 8.4 times. Analysts see it undervalued by as much as 65% compared to its intrinsic value. It's considered a unique business, more like a "mini Berkshire Hathaway," suitable for investors seeking exposure to the sector in a contrarian way.
• Algonquin Power & Renewables: Not owned. The company is in a multi-year turnaround due to higher interest costs and slower execution. It has a mix of regulated utilities in the US and Canada, providing stable electricity, gas, and water operations. The company is simplifying its business, focusing on regulated utilities for steadier cash flows. Cautious due to leverage and past execution issues, especially when other utilities offer cleaner stories. Brookfield Infrastructure, Capital Power, and Hydro One are preferred alternatives. Value ranks 8/10, fundamentally 7/10. A 5% pullback is recommended before entering a position for growth in a TFSA.
• Capital One: Not owned. A strong player in credit card and digital banking. JP Morgan is preferred for broader US financial exposure. Fundamentally scores 8/10, but value score is 4/10. Analysts expect about 20% potential upside. Analysts have strong "buy and outperform" ratings. Volatility has been present year-to-date. Underwriting has been tightened, and reserves built, helping manage a slower consumer environment. Card spending is holding up, and digital deposits are growing. The long-term setup is positive.
• Element (Couche-Tard): 13% upside potential based on analyst targets. A convenience store/gas station model with resilient business model and everyday consumer demand, expected to do well even with consumer spending slowdowns. Scale and operational efficiencies help maintain steady margins. Recent performance has been mixed, trending sideways for a year. The company continues to invest in store upgrades and digital initiatives. Modest dividend. Value comes from cash generation and reinvestment in growth. Remains constructive long-term, ranking 9/10 fundamentally.

Technology:

• Meta Platforms (META): Still owned and bullish on the stock. The recent dip is seen as a great opportunity to add to positions, especially for newer clients with cash. Reels are a major growth driver ($50 billion/year). Aggressively leaning into AI. The $16 billion tax charge was a one-time hit. Underlying fundamentals remain solid. Over 30% upside is seen, ranking 9/10 fundamentally. Concerns about AI capex are noted, with a "wait and see" approach on ROI, but historical investment cycles have paid off.
• Microsoft (MSFT): Owned for years and a best long-term holding. The current short-term breather is an opportunity to add to positions. Seen as the heartbeat of enterprise cloud AI. New partnerships are expanding its AI ecosystem and reducing dependence on single model providers. Purchase of $30 billion compute on Azure strengthens cloud demand visibility. Not as worried about circularity due to its broad ecosystem built on Azure and Office, rather than a tight loop like some others. Growth is broad, not concentrated. Ranks 10/10 fundamentally, with 30% upside seen.

Consumer Discretionary/Retail:

• Costco (COST): Stock has pulled back from February highs but is still liked. Shoppers are loyal due to value, with renewal rates close to 90%. Sales are growing faster than Walmart and Target. Added over 4 million new paying members last year. Digital commerce is becoming a real contributor (26% jump in online sales in September). Fee increases are boosting high margins. Plans for 30 new stores this year, including international expansion. Double-digit upside (almost 20%) is expected. Fundamentally ranks 10/10.
• Aritzia (AZ): In the consumer discretionary space, the firm has been underweight due to concerns about consumer spending. Aritzia is a strong Canadian brand, outperforming Lululemon. It's working through a rebranding phase after a tougher stretch in the US. Focus on premium everyday apparel and a vertical integration model provides control over design, pricing, and margins. Demand is stabilizing, US traffic trends have improved, and new stores are performing well. Growth plan remains intact with boutique openings, brand refreshes, and e-commerce improvements. Financially recovering, margins improving, inventories normalizing. Fundamentally strong (9/10), but value score is 1/10. Analysts rank it "buy and outperform," but a pullback in the stock is expected in the short term.

Healthcare/Medical Devices:

• Eli Lilly (LLY): Has had a strong rally, hitting all-time highs and becoming the first pharmaceutical company to reach a $1 trillion market cap. It's at its original target price, with re-evaluation for a new target price suggesting potentially 50% upside. Strongest growth story in healthcare, led by breakthrough weight loss and diabetes medicine. Demand is incredible, reshaping patient management of weight and metabolic health. Building new facilities. The weight loss drug market is expected to surpass $100 billion, with Lilly positioned to capture a significant share. Late-stage opportunities in Alzheimer's and oncology could add further long-term growth. Still owned, with potential to take some profits.
• Boston Scientific (BSX): A recent addition. Makes less invasive devices for heart issues and chronic pain. Becoming a leader in treating irregular heartbeats and improving stroke prevention devices. Hospitals are choosing their solutions. Financially solid with strong margins, allowing investment in new technologies and steady long-term growth. The aging population will increase their consumer base. Ranks 8/10, with about 26% upside and a price target of $128. Operates globally and continues to expand into global markets.

Utilities/Energy Infrastructure:

• Constellation Energy (CEG): The largest producer of clean power in the US, supplying about 10% of America's carbon-free electricity. Added during the April sell-off and has become a strong contributor. Stability of the business stands out, with nuclear plants running with high reliability, providing earnings visibility. Growth is accelerating with major power deals signed with data centers. Double-digit earnings growth is expected through 2030. Double-digit upside is seen, with a price target of around $405. Fundamentally ranks 8/10.
• AltaGas: Not owned. A utilities and midstream company with steady cash flow from natural gas distribution and energy infrastructure assets. The utility segment provides stability, while export and storage add growth. Both segments move with natural gas, which has been trending upwards. Year-to-date return is about 30%. Hydro One, Brookfield, and Capital Power are preferred utilities. Value ranks 8/10, fundamentally 7/10. Analysts expect 8-10% price target upside. A 5% pullback is recommended before entering a position for more upside growth in a TFSA.

Telecommunications:

• Telus (T): In the portfolio, but has been a challenging performer recently. Down year-to-date and over the past 12 months. Concerns about the dividend being cut, currently offering a 9% dividend yield. The business is stable, but growth has slowed due to intensifying competition, putting pressure on cash flow. Telus is investing in digital health to diversify revenue and improve long-term growth prospects. Cautious on the stock. Value ranks 9/10. A 15% holding in a TFSA is considered a heavy weight, but holding it out is advised.

Past Picks Review

• Meta Platforms (META): Still owned and bullish. The recent dip was used to add to positions. Reels are a major growth driver. Aggressively leaning into AI. Over 30% upside seen, ranks 9/10 fundamentally.
• Costco (COST): Still liked. Shoppers are loyal due to value. Sales growing faster than Walmart and Target. Digital commerce is a contributor. Double-digit upside (almost 20%) expected. Fundamentally ranks 10/10.
• Eli Lilly (LLY): Has had a strong rally, hitting all-time highs and a $1 trillion market cap. Potential for another 50% upside seen due to breakthrough weight loss and diabetes medicine. Still owned, with potential to take some profits.

Outlook for Year-End and 2026

As the year ends, consumers are reining in spending due to concerns about inflation and job security. Muted volatility is expected, with a potential short-term sell-off towards year-end or into January, which is considered normal and healthy. Economic data is being closely watched, and the positioning for 2026 will be key. Historically, markets have been bullish two years after a sharp V-shaped recovery (like April 2020), leading to optimism for 2026.

Conclusion

The overall sentiment is cautiously optimistic, with a focus on quality, diversification, and strategic positioning for the coming years. While economic headwinds exist, particularly concerning consumer spending, specific sectors and companies are identified as having strong fundamentals and growth potential. Volatility is viewed as an opportunity to refine portfolios and invest in high-quality assets. The outlook for 2026 is generally positive, supported by ongoing technological advancements (especially AI) and a potential shift in monetary policy.